TY - JOUR
T1 - Predictor of left ventricular dysfunction after aortic valve replacement in mixed aortic valve disease
AU - Egbe, Alexander
AU - Warnes, Carole A.
PY - 2017/2/1
Y1 - 2017/2/1
N2 - Background The fate of the left ventricle (LV) after aortic valve replacement (AVR) in mixed aortic valve disease (MAVD) is unknown. Methods Patients with moderate-severe MAVD, ejection fraction ≥ 50%, and no coronary artery disease who underwent AVR were identified. Moderate-severe MAVD was defined as a combination of ≥ moderate aortic stenosis and ≥ moderate aortic regurgitation. Assessment for LVD was performed at 1 and 5 years after AVR. The purpose of the study was to determine prevalence and predictors of early and late left ventricular dysfunction (LVD) defined as ejection fraction < 50% at 1 and 5 years post-AVR. The severity of LV hypertrophy was assessed using LV mass index (LVMI), while relative wall thickness (RWT) was used to determine the type of hypertrophy. RWT was calculated as (2 × posterior wall thickness) / LV end-diastolic dimension (LVEDD). A RWT score ≥ 0.42 and < 0.42 indicates concentric and eccentric hypertrophy respectively. Results Patients with MAVD (n = 179); age 63 ± 8 years, males 134 (75%); underwent AVR at Mayo Clinic, 1994–2010. Early LVD occurred in 38(21%). Predictors of early LVD were LVMI/LVEDD > 3.1 (HR 1.83, CI 1.59–1.98); RWT > 0.46 (HR 2.16, CI 1.21–4.99); and older age (HR 1.62, CI 1.23–3.02). Assessment of LV function was performed in 124 patients at 5-years post-AVR, and late LVD was present in 29(23%). Predictors of late LVD were LVMI/LVEDD > 3.1 (HR 1.77, CI 1.24–2.01) and RWT > 0.46 (HR 1.65, CI 1.29–2.24). All-cause mortality occurred in 21(12%), and was more common in patients with LVMI/LVEDD > 3.1 (P = 0.043) and RWT > 0.46 (P = 0.029). Patients with postoperative LVD showed less regression of LV mass after AVR even after controlling for blood pressure. Conclusions LVD can occur after AVR even in the setting of normal preoperative LV function and absence of coronary artery disease. Preoperative LV mass was predictive of LVD and should be taken into consideration when determining the timing of AVR.
AB - Background The fate of the left ventricle (LV) after aortic valve replacement (AVR) in mixed aortic valve disease (MAVD) is unknown. Methods Patients with moderate-severe MAVD, ejection fraction ≥ 50%, and no coronary artery disease who underwent AVR were identified. Moderate-severe MAVD was defined as a combination of ≥ moderate aortic stenosis and ≥ moderate aortic regurgitation. Assessment for LVD was performed at 1 and 5 years after AVR. The purpose of the study was to determine prevalence and predictors of early and late left ventricular dysfunction (LVD) defined as ejection fraction < 50% at 1 and 5 years post-AVR. The severity of LV hypertrophy was assessed using LV mass index (LVMI), while relative wall thickness (RWT) was used to determine the type of hypertrophy. RWT was calculated as (2 × posterior wall thickness) / LV end-diastolic dimension (LVEDD). A RWT score ≥ 0.42 and < 0.42 indicates concentric and eccentric hypertrophy respectively. Results Patients with MAVD (n = 179); age 63 ± 8 years, males 134 (75%); underwent AVR at Mayo Clinic, 1994–2010. Early LVD occurred in 38(21%). Predictors of early LVD were LVMI/LVEDD > 3.1 (HR 1.83, CI 1.59–1.98); RWT > 0.46 (HR 2.16, CI 1.21–4.99); and older age (HR 1.62, CI 1.23–3.02). Assessment of LV function was performed in 124 patients at 5-years post-AVR, and late LVD was present in 29(23%). Predictors of late LVD were LVMI/LVEDD > 3.1 (HR 1.77, CI 1.24–2.01) and RWT > 0.46 (HR 1.65, CI 1.29–2.24). All-cause mortality occurred in 21(12%), and was more common in patients with LVMI/LVEDD > 3.1 (P = 0.043) and RWT > 0.46 (P = 0.029). Patients with postoperative LVD showed less regression of LV mass after AVR even after controlling for blood pressure. Conclusions LVD can occur after AVR even in the setting of normal preoperative LV function and absence of coronary artery disease. Preoperative LV mass was predictive of LVD and should be taken into consideration when determining the timing of AVR.
KW - Aortic valve replacement
KW - Left ventricle dysfunction
KW - Left ventricular mass
KW - Mixed aortic valve disease
UR - http://www.scopus.com/inward/record.url?scp=84997047885&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84997047885&partnerID=8YFLogxK
U2 - 10.1016/j.ijcard.2016.11.237
DO - 10.1016/j.ijcard.2016.11.237
M3 - Article
C2 - 27875727
AN - SCOPUS:84997047885
SN - 0167-5273
VL - 228
SP - 511
EP - 517
JO - International Journal of Cardiology
JF - International Journal of Cardiology
ER -